Findings from recently completed trials indicate that a GLP-1 RA-induced increase in HR, regardless of magnitude, does not present an increased cardiovascular risk for subjects with T2DM, although a pronounced increase in HR may be associated with adverse clinical outcomes in those with advanced heart failure
Also Read: 5 Eye-Opening Things Science Got Wrong (And Right) about Ozempic Should I stop my GLP-1 medication if Im concerned about bone health
doi:10.3389/fnagi.2021.679711 Kawas LH, et al
"Ang rinig ko dito sa mga facilities na sinasabi ay 'yung kumakalikot sa mukha ay hindi manlang doktor, 'yun problema 'yun at dapat ipasara ito (What I hear about the facilities being mentioned is that those meddling with the face aren't even doctors
Yet many patients are prescribed them with little discussion beyond body weight, nausea, constipation, and refill timing